Jia Fan

Active 1998–2026

Also published as
Jia, Fan
543
Papers
62,932
Citations
132
h-index
489
i10-index

Citations

Citations per year for Jia Fan1926: 1 citations1939: 1 citations1979: 1 citations1991: 1 citations1992: 1 citations1995: 1 citations1997: 1 citations1999: 3 citations2000: 1 citations2001: 4 citations2002: 3 citations2003: 10 citations2004: 6 citations2005: 14 citations2006: 17 citations2007: 28 citations2008: 61 citations2009: 88 citations2010: 146 citations2011: 197 citations2012: 265 citations2013: 349 citations2014: 351 citations2015: 385 citations2016: 342 citations2017: 449 citations2018: 500 citations2019: 1,888 citations2020: 2,963 citations2021: 3,130 citations2022: 2,952 citations2023: 2,839 citations2024: 5,111 citations2025: 3,020 citations2026: 75 citations1927–1938: no citations, so these years are not shown1940–1978: no citations, so these years are not shown1980–1990: no citations, so these years are not shown1993–1994: no citations, so these years are not shown1996: no citations, so this year is not shown1998: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 11,894 citing papers, 41.8% of this breakdownUnited States: 4,185 citing papers, 14.7% of this breakdownItaly: 982 citing papers, 3.4% of this breakdownGermany: 886 citing papers, 3.1% of this breakdownUnited Kingdom: 829 citing papers, 2.9% of this breakdownJapan: 711 citing papers, 2.5% of this breakdownSouth Korea: 561 citing papers, 2% of this breakdownFrance: 551 citing papers, 1.9% of this breakdownIndia: 504 citing papers, 1.8% of this breakdownSpain: 473 citing papers, 1.7% of this breakdownCanada: 448 citing papers, 1.6% of this breakdownHong Kong: 438 citing papers, 1.5% of this breakdown
0%41.8%Other 21.1%

Fields

  • Medicine46.7%
  • Biochemistry, Genetics and Molecular Biology38.6%
  • Immunology and Microbiology9%
  • Engineering1.3%
  • Neuroscience0.8%
  • Computer Science0.8%
  • Other2.8%

Topics

  • Hepatocellular Carcinoma Treatment and Prognosis4.9%
  • Cancer Immunotherapy and Biomarkers3.9%
  • MicroRNA in disease regulation3.5%
  • Cancer-related molecular mechanisms research3.4%
  • Immune cells in cancer3.1%
  • RNA modifications and cancer2.8%
  • Other78.4%

Coauthors

All papers

Open in search
  1. Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma

    Authors: , , , , , , , , , , - Clinical Cancer Research 2014 cited by 2,342

  2. Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level

    Authors: , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2021 cited by 1,188

  3. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , - Nature Metabolism 2023 cited by 545

  4. Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gao‐Jun Teng, Yanru Qin, Jinhai Wang, Feng Xia, Guowen Yin, Yong Yang, Mingxia Chen, Yan Wang, Hui Zhou, Jia Fan - The Lancet Oncology 2021 cited by 1,115

  5. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yaguang Zhang, Shiping Liu, Xin‐Rong Yang, Jia Fan - Cell 2020 cited by 957

  6. Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2019 cited by 1,180

  7. CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor

    Authors: , , , , , , , , , , , , , , , , , , , - Cell Discovery 2023 cited by 311

  8. Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Baojin Hua, Xiaowu Huang, Weidong Jia, Yaming Li, Ye‐Xiong Li, Jun Liang, Tianshu Liu, Guoyue Lv, Yilei Mao, Tao Peng, Weixin Ren, Hongcheng Shi, Guo‐Ming Shi, Kaishan Tao, Wentao Wang, Xiaoying Wang, Zhiming Wang, Bang‐De Xiang, Baocai Xing, Jianming Xu, Jiamei Yang, Jianyong Yang, Yefa Yang, Yunke Yang, Sheng‐Long Ye, Zhengyu Yin, Bixiang Zhang, Boheng Zhang, Leida Zhang, Shuijun Zhang, Ti Zhang, Yongfu Zhao, Honggang Zheng, Jiye Zhu, Kangshun Zhu, Rong Liu, Ying–Hong Shi, Yong‐Sheng Xiao, Zhi Dai, Gao‐Jun Teng, Jianqiang Cai, Weilin Wang, Xiujun Cai, Qiang Li, Feng Shen, Shukui Qin, Jiahong Dong, Jia Fan - Liver Cancer 2020 cited by 833

  9. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zhenyu Wu, Tieliu Shi, Weimin Zhu, Jun Qin, Lu Xie, Jia Fan, Xiaohong Qian, Fuchu He - Nature 2019 cited by 990

  10. FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling

    Authors: , , , , , , , , , - Cancer Research 2016 cited by 744

  11. Neutrophil profiling illuminates anti-tumor antigen-presenting potency

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cell 2024 cited by 445

  12. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib

    Authors: , , , , , , , , , - Gastroenterology 2016 cited by 895

  13. An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte–tumor cell crosstalk, local immunosuppression and tumor progression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Haixiang Sun, Na Yao, Xiangyu Zhang, Shiyu Zhang, Xi Chen, Yang Yu, Yao Li, Fengming Liu, Zheng Wang, Shao‐Lai Zhou, Huanming Yang, Shuang Yang, Xun Xu, Longqi Liu, Qiang Gao, Zhao–You Tang, Xiangdong Wang, Jian Wang, Jia Fan, Shiping Liu, Xin‐Rong Yang, Ao Chen, Jian Zhou, Ao Chen, Jian Zhou - Cell Research 2023 cited by 218

  14. Precision treatment in advanced hepatocellular carcinoma

    Authors: , , , , , , , , , - Cancer Cell 2024 cited by 393

  15. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hu Zhou, Jia Fan - Cancer Cell 2021 cited by 414

  16. Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric X. Chen, Ying Cheng, Antonio Cubillo Gracián, Laëtitia Dahan, Filippo de Braud, Elisabetta Fenocchio, Olumide Gbolohon, Roopinder Gillmore, Marine Jary, Milind Javle, Yixing Jiang, Jung Hun Kang, Gentry George King, Madappa N. Kundranda, Laura Layos, Daneng Li, Tingbo Liang, Sara Lonardi, Omkar Marathe, Sebastián Mondaca, Andrés J. Muñoz Martín, Joon Oh Park, Roberto Pazo-Cid, Paula Ribera Fernandez, Lorenza Rimassa, Rosa Alonso, Saeed Sadeghi, Aaron J. Scott, Benjamin Tan, David Tougeron, Qiang Yan, Xiaoyu Yin, Haitao Zhao - The Lancet Oncology 2023 cited by 247

  17. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation

    Authors: , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2022 cited by 262

  18. Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2021 cited by 246

  19. Changing epidemiology of hepatocellular carcinoma in Asia

    Authors: , , , , - Liver International 2022 cited by 339

  20. IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment

    Authors: , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2022 cited by 205

  21. Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , - Gastroenterology 2017 cited by 640

  22. N6-Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation

    Authors: , , , , , , , , , , , , , , , - Nature Chemical Biology 2018 cited by 402

  23. A blueprint for tumor-infiltrating B cells across human cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2024 cited by 200

  24. Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2022 cited by 151